אמביזום

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Koop het nu

Werkstoffen:

AMPHOTERICIN B

Beschikbaar vanaf:

GILEAD SCIENCES ISRAEL LTD

ATC-code:

J02AA01

farmaceutische vorm:

אבקה להכנת תרכיז לאינפוזיה

Samenstelling:

AMPHOTERICIN B 50 MG/VIAL

Toedieningsweg:

תוך-ורידי

Prescription-type:

מרשם נדרש

Geproduceerd door:

GILEAD SCIENCES IRELAND UC, IRELAND

Therapeutische categorie:

AMPHOTERICIN B

Therapeutisch gebied:

AMPHOTERICIN B

therapeutische indicaties:

Antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin B in effective dosages. This drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. Ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with AIDS or cancer). Ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. HIV positive). Empirical treatment of presumed fungal infection in febrile neutropenic patients.

Autorisatie datum:

2015-02-28

Documenten in andere talen

Productkenmerken Productkenmerken Engels 17-08-2016
Openbaar beoordelingsrapport Openbaar beoordelingsrapport Engels 18-08-2016

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten